Oedema drug may benefit children with ASD: study

It's worth considering but under close medical supervision, US expert says
Reuters Health Staff writer
Boy

Three months of treatment with a bumetanide, a drug used to treat oedema, improves autism spectrum disorder (ASD) symptoms in children aged 3-6, a clinical trial suggests.

Chinese researchers randomly assigned 83 children with severe ASD to 0.5mg bumetanide twice a day for three months or placebo.